{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:23:09Z","timestamp":1780363389955,"version":"3.54.1"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2019\/35\/B\/NZ5\/04208"],"award-info":[{"award-number":["2019\/35\/B\/NZ5\/04208"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-24-0242"],"award-info":[{"award-number":["APVV-24-0242"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioorg.2026.109517","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T15:41:50Z","timestamp":1768664510000},"page":"109517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An insight into the anticancer potential of sulfonated styrylquinazolines as multifunctional agents targeting microtubules."],"prefix":"10.1016","volume":"170","author":[{"given":"Patryk","family":"Rurka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Mularski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Ziola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Boguszewska-Czubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Jampilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mrozek-Wilczkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Malarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bioorg.2026.109517_bb0005","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.tcb.2018.05.001","article-title":"Microtubule-targeting agents: strategies to hijack the cytoskeleton","volume":"28","author":"Steinmetz","year":"2018","journal-title":"Trends Cell Biol."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109517_bb0010","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1158\/1078-0432.CCR-06-3040","article-title":"Microtubule-associated proteins as targets in cancer chemotherapy","volume":"13","author":"Bhat","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109517_bb0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1025513106330","article-title":"Microtubules, microtubule-interfering agents and apoptosis","volume":"8","author":"Mollinedo","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2026.109517_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.935493","article-title":"Emerging role of microtubule-associated proteins on cancer metastasis","volume":"13","author":"Wattanathamsan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.bioorg.2026.109517_bb0025","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.216168","article-title":"Loss of CAMSAP3 promotes EMT via the modification of microtubule-Akt machinery","volume":"131","author":"Pongrakhananon","year":"2018","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109517_bb0030","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3390\/ijms18071434","article-title":"An emerging role for tubulin isotypes in modulating cancer biology and chemotherapy resistance","volume":"18","author":"Parker","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109517_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chembiol.2013.01.014","article-title":"The binding sites of microtubule-stabilizing agents","volume":"20","author":"Field","year":"2013","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0040","first-page":"82","article-title":"Resistance to anti-tubulin agents: from vinca alkaloids to epothilones","volume":"2","author":"Krause","year":"2019","journal-title":"Cancer Drug Resist"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109517_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.46","article-title":"Microtubule-targeting agents for cancer treatment: seven binding sites and three strategies","volume":"2","author":"Wang","year":"2023","journal-title":"MedComm \u2013Oncology"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109517_bb0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/toxics3020152","article-title":"Taxane-induced peripheral neurotoxicity","volume":"3","author":"Velasco","year":"2015","journal-title":"Toxics"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109517_bb0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/1878-0261.13536","article-title":"Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance","volume":"18","author":"Hsieh","year":"2024","journal-title":"Mol. Oncol."},{"issue":"16_suppl","key":"10.1016\/j.bioorg.2026.109517_bb0060","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1200\/JCO.2024.42.16_suppl.3114","article-title":"The microtubule-destabilizing agent AUS_001 as a candidate for glioblastoma therapy","volume":"42","author":"Koutsioumpa","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109517_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020406","article-title":"Novel brain-penetrant, small-molecule tubulin destabilizers for the treatment of glioblastoma","volume":"12","author":"Patron","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109517_bb0070","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/acs.jnatprod.9b00105","article-title":"Microtubule-targeting drugs: more than antimitotics","volume":"82","author":"Kaul","year":"2019","journal-title":"J. Nat. Prod."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109517_bb0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/15384101.2020.1716144","article-title":"The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner","volume":"19","author":"Husemann","year":"2020","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0080","doi-asserted-by":"crossref","first-page":"13124","DOI":"10.1038\/s41598-020-68986-0","article-title":"Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway","volume":"10","author":"Andersson","year":"2020","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.bioorg.2026.109517_bb0085","doi-asserted-by":"crossref","first-page":"23024","DOI":"10.1021\/acs.jmedchem.5c01888","article-title":"Dual induction of ferroptosis and apoptosis by Triazolopyrimidinyl derivatives: design, synthesis, and biological evaluation for their anticancer efficacy via calcium\/calmodulin Signaling and mitochondrial impairment","volume":"68","author":"Chen","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3892\/ijo.2012.1710","article-title":"Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells","volume":"42","author":"Wu","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.201004145","article-title":"Microtubule disruption targets HIF-1\u03b1 mRNA to cytoplasmic P-bodies for translational repression","volume":"192","author":"Carbonaro","year":"2011","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109517_bb0100","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/bjc.2014.80","article-title":"Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial\u2013mesenchymal transition (EMT) to mesenchymal\u2013epithelial transition (MET) states","volume":"110","author":"Yoshida","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.bioorg.2026.109517_bb0105","doi-asserted-by":"crossref","first-page":"15006","DOI":"10.1021\/acs.jmedchem.3c01690","article-title":"Design, synthesis, and antitumor efficacy of substituted 2-amino[1,2,4]triazolopyrimidines and related heterocycles as dual inhibitors for microtubule polymerization and Janus kinase 2","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109517_bb0110","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002594R","article-title":"Microtubule-targeting agents impair kinesin-2-dependent nuclear transport of \u03b2-catenin: evidence of inhibition of Wnt\/\u03b2-catenin signaling as an important antitumor mechanism of microtubule-targeting agents","volume":"35","author":"Kumari","year":"2021","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109517_bb0115","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1021\/acs.jmedchem.1c01714","article-title":"Development of dual inhibitors targeting epidermal growth factor receptor in cancer therapy","volume":"65","author":"Tan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109517_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107087","article-title":"Design of balanced dual-target inhibitors of EGFR and microtubule","volume":"143","author":"Liu","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109517_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117000","article-title":"Discovery of novel quinazoline derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potential anti-colon cancer effects","volume":"280","author":"Zhu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109517_bb0130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/1871520620666191224122204","article-title":"Evaluation of anticancer and anti-mitotic properties of quinazoline and quinazolino-benzothiadiazine derivatives","volume":"20","author":"Shaik","year":"2020","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.bioorg.2026.109517_bb0135","first-page":"610","article-title":"The p53 stabilizing agent CP-31398 and multi-kinase inhibitors","volume":"163","author":"Mularski","year":"2019","journal-title":"Designing, synthesizing and screening of styrylquinazoline series, Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0140","doi-asserted-by":"crossref","first-page":"16081","DOI":"10.1038\/s41598-025-99277-1","article-title":"Unveiling the role of Ndrg1 gene on the oxidative stress induction behind the anticancer potential of styrylquinazoline derivatives","volume":"15","author":"Malarz","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2201410","article-title":"Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations","volume":"38","author":"Malarz","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109517_bb0150","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.3390\/cancers13081790","article-title":"Novel benzenesulfonate scaffolds with a high anticancer activity and G2\/M cell cycle arrest","volume":"13","author":"Malarz","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0155","doi-asserted-by":"crossref","first-page":"28454","DOI":"10.1038\/s41598-024-79698-0","article-title":"4-Furanylvinylquinoline derivative as a new scaffold for the design of oxidative stress initiator and glucose transporter inhibitor drugs","volume":"14","author":"Kuczak","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109517_bb0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejmech.2019.05.061","article-title":"The synthesis and anticancer activity of 2-styrylquinoline derivatives. A p53 independent mechanism of action","volume":"177","author":"Mrozek-Wilczkiewicz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109517_bb0165","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/nar\/gkn1085","article-title":"Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences","volume":"37","author":"Br\u00e1zdov\u00e1","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109517_bb0170","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0145-2126(93)90161-D","article-title":"Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line","volume":"17","author":"Law","year":"1993","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0175","article-title":"A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis","volume":"3","author":"Horne","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109517_bb0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1021\/acsptsci.9b00045","article-title":"Lower tubulin expression in glioblastoma stem cells attenuates efficacy of microtubule-targeting agents","volume":"2","author":"Abbassi","year":"2019","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"Pt 19","key":"10.1016\/j.bioorg.2026.109517_bb0185","first-page":"4111","article-title":"The role of mitotic kinases in coupling the centrosome cycle with the assembly of the mitotic spindle","volume":"127","author":"Wang","year":"2014","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109517_bb0190","article-title":"Synthesis and screening of novel 2,4-bis substituted quinazolines as tubulin polymerization promoters and antiproliferative agents, RSC","volume":"16","author":"Dwivedi","year":"2025","journal-title":"Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109517_bb0195","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/acs.jcim.8b00704","article-title":"Conformator: a novel method for the generation of conformer ensembles","volume":"59","author":"Friedrich","year":"2019","journal-title":"J. Chem. Inf. Model."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109517_bb0200","first-page":"2207","article-title":"Regulation of p27(Kip1) phosphorylation and G1 cell cycle progression by protein phosphatase PPM1G","volume":"6","author":"Sun","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109517_bb0205","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/sj.bjc.6603448","article-title":"Upregulation of p27 and its inhibition of CDK2\/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21","volume":"95","author":"He","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2026.109517_bb0210","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11993","article-title":"IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87-MG cells","volume":"23","author":"Gao","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2026.109517_bb0215","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.2147\/OTT.S222223","article-title":"GADD45a mediated cell cycle inhibition is regulated by p53 in bladder cancer","volume":"12","author":"Han","year":"2019","journal-title":"Onco. Targets. Ther."},{"issue":"57","key":"10.1016\/j.bioorg.2026.109517_bb0220","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1038\/sj.onc.1206034","article-title":"GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity","volume":"21","author":"Jin","year":"2002","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109517_bb0225","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4161\/cc.7.8.5738","article-title":"Requirement of aurora-a kinase in astral microtubule polymerization and spindle microtubule flux","volume":"7","author":"Wang","year":"2008","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0230","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1038\/s41467-020-18872-0","article-title":"Synthetic lethality of RB1 and aurora a is driven by stathmin-mediated disruption of microtubule dynamics","volume":"11","author":"Lyu","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109517_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000225","article-title":"Tubulin mRNA stability is sensitive to change in microtubule dynamics caused by multiple physiological and toxic cues","volume":"17","author":"Gasic","year":"2019","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109517_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071652","article-title":"PI3K\/AKT signaling tips the balance of cytoskeletal forces for cancer progression","volume":"14","author":"Deng","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.bioorg.2026.109517_bb0245","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M117.785832","article-title":"Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells","volume":"292","author":"Mercado-Matos","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109517_bb0250","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1074\/jbc.M109.042754","article-title":"The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation","volume":"285","author":"Gao","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109517_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094134","article-title":"Cytoplasmic retention of a nucleocytoplasmic protein TBC1D3 by microtubule network is required for enhanced EGFR signaling","volume":"9","author":"He","year":"2014","journal-title":"PloS One"},{"issue":"515","key":"10.1016\/j.bioorg.2026.109517_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaq1060","article-title":"KIF22 coordinates CAR and EGFR dynamics to promote cancer cell proliferation","volume":"11","author":"Pike","year":"2018","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-019-0723-9","article-title":"A homogeneous bioluminescent immunoassay to probe cellular signaling pathway regulation","volume":"3","author":"Hwang","year":"2020","journal-title":"Communications Biology"},{"issue":"17","key":"10.1016\/j.bioorg.2026.109517_bb0270","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.4161\/cc.7.17.6514","article-title":"PI3-K and GSK-3: Akt-ing together with microtubules","volume":"7","author":"Buttrick","year":"2008","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109517_bb0275","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.cellsig.2014.04.007","article-title":"Microtubule dynamics regulates Akt signaling via dynactin p150","volume":"26","author":"Jo","year":"2014","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109517_bb0280","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1158\/1535-7163.MCT-06-0639","article-title":"Blockade of the phosphatidylinositol-3-kinase\u2013Akt signaling pathway enhances the induction of apoptosis by microtubule-destabilizing agents in tumor cells in which the pathway is constitutively activated","volume":"6","author":"Fujiwara","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109517_bb0285","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3324\/haematol.2013.098442","article-title":"Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy","volume":"99","author":"Bibi","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109517_bb0290","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031450","article-title":"PI3K: a crucial piece in the RAS signaling puzzle","volume":"8","author":"Krygowska","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109517_bb0295","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1074\/jbc.273.9.4928","article-title":"Microtubule-interfering agents activate c-Jun N-terminal kinase\/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways","volume":"273","author":"Wang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109517_bb0300","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bioorg.2018.03.027","article-title":"Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes","volume":"78","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0305","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/14756366.2021.1925265","article-title":"Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line","volume":"36","author":"Gonzalez","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0310","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-019-1047-9","article-title":"CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109517_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12749","article-title":"Microtubule disrupting agent-mediated inhibition of cancer cell growth is associated with blockade of autophagic flux and simultaneous induction of apoptosis","volume":"53","author":"Hasanain","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bioorg.2026.109517_bb0320","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.taap.2016.09.021","article-title":"A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells","volume":"311","author":"Wei","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"31","key":"10.1016\/j.bioorg.2026.109517_bb0325","doi-asserted-by":"crossref","first-page":"24184","DOI":"10.1074\/jbc.M109.091553","article-title":"Starvation-induced hyperacetylation of tubulin is required for the stimulation of autophagy by nutrient deprivation","volume":"285","author":"Geeraert","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109517_bb0330","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104309119","article-title":"A role for endoplasmic reticulum dynamics in the cellular distribution of microtubules","volume":"119","author":"Tikhomirova","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109517_bb0335","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1074\/jbc.RA118.005166","article-title":"The ER-localized ca(2+)-binding protein calreticulin couples ER stress to autophagy by associating with microtubule-associated protein 1A\/1B light chain 3","volume":"294","author":"Yang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109517_bb0340","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/tra.12372","article-title":"Nuclear LC3 associates with slowly diffusing complexes that survey the nucleolus","volume":"17","author":"Kraft","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.bioorg.2026.109517_bb0345","series-title":"Styryl Quinazoline Derivatives As Pharmaceutically Active Agents","author":"Baska","year":"2014"},{"key":"10.1016\/j.bioorg.2026.109517_bb0350","series-title":"Quinazolinone and Quinazoline Derivatives, IntechOpen, Rijeka","article-title":"4(3H)-quinazolinone derivatives: Syntheses, physical properties, chemical reaction, and biological properties","author":"Samir","year":"2020"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109517_bb0355","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/scipharm91020018","article-title":"Medicinal chemistry of quinazolines as anticancer agents targeting tyrosine kinases","volume":"91","author":"Zayed","year":"2023","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2026.109517_bb0360","author":"Lipinski","year":"2001"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109517_bb0365","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.xphs.2023.07.006","article-title":"Solubility-permeability interplay in facilitating the prediction of drug disposition routes, extent of absorption, food effects, brain penetration and drug induced liver injury potential","volume":"112","author":"Benet","year":"2023","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109517_bb0370","first-page":"721","article-title":"Molecular properties, including chameleonicity, as essential tools for designing the next generation of oral beyond rule of five drugs","volume":"12","author":"Jimenez","year":"2024","journal-title":"ADMET & DMPK"},{"key":"10.1016\/j.bioorg.2026.109517_bb0375","series-title":"The Practice of Medicinal Chemistry","first-page":"481","article-title":"Chapter 22 - compound properties and drug quality","author":"Lipinski","year":"2008"},{"key":"10.1016\/j.bioorg.2026.109517_bb0380","series-title":"Comprehensive Medicinal Chemistry II","first-page":"669","article-title":"5.28 - in silico models to predict oral absorption","author":"Van de Waterbeemd","year":"2007"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109517_bb0385","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10822-011-9478-1","article-title":"Qualitative prediction of blood\u2013brain barrier permeability on a large and refined dataset","volume":"25","author":"Muehlbacher","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0390","first-page":"1","article-title":"Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-tox screening in drug discovery and development: a comprehensive review","volume":"11","author":"Chunduri","year":"2023","journal-title":"ADMET & DMPK"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0395","article-title":"Often neglected steps in transforming drug solubility from single measurement in pure water to physiologically-appropriate solubility-pH","volume":"13","author":"Avdeef","year":"2025","journal-title":"ADMET and DMPK"},{"key":"10.1016\/j.bioorg.2026.109517_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107528","article-title":"Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trials","volume":"212","author":"Pinto-Fraga","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0405","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/neuonc\/nov164","article-title":"Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma","volume":"18","author":"Oberoi","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bioorg.2026.109517_bb0410","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2147\/IJN.S231479","article-title":"Overcoming the blood-brain barrier: successes and challenges in developing nanoparticle-mediated drug delivery systems for the treatment of brain tumours","volume":"15","author":"Ferraris","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"15","key":"10.1016\/j.bioorg.2026.109517_bb0415","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.3390\/ijms26157050","article-title":"Beyond the walls of Troy: a scoping review on pharmacological strategies to enhance drug delivery across the blood\u2013brain barrier and blood\u2013tumor barrier","volume":"26","author":"Pinkiewicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109517_bb0420","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1002\/cam4.3061","article-title":"The underlying mechanisms of lorlatinib penetration across the blood-brain barrier and the distribution characteristics of lorlatinib in the brain","volume":"9","author":"Chen","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.bioorg.2026.109517_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120100","article-title":"Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells","volume":"287","author":"Momeny","year":"2021","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109517_bb0430","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.3390\/pharmaceutics14122706","article-title":"Insights into lipid-based delivery nanosystems of protein-tyrosine kinase inhibitors for cancer therapy","volume":"14","author":"Jampilek","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109517_bb0435","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3390\/pharmaceutics13091446","article-title":"Brain metastasis treatment: the place of tyrosine kinase inhibitors and how to facilitate their diffusion across the blood\u2013brain barrier","volume":"13","author":"Angeli","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109517_bb0440","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12967-025-06448-9","article-title":"Application of EGFR-TKIs in brain tumors, a breakthrough in future?","volume":"23","author":"Feng","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2026.109517_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118692","article-title":"The multifaceted mechanism of action of quinoline thiosemicarbazone based on disruption of iron homeostasis and selective IGF1R inhibition leading to oxidative stress induction","volume":"192","author":"Zio\u0142a","year":"2025","journal-title":"Biomed. Pharmacother."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:44:07Z","timestamp":1773978247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":89,"alternative-id":["S0045206826000532"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109517","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An insight into the anticancer potential of sulfonated styrylquinazolines as multifunctional agents targeting microtubules.","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109517"}}